Abiopharma

SC 13G/A (Amended Statement of Ownership) SEC Filing

DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – DXCM

UTHR: Notification

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom

Fresenius Medical Care marks World Diabetes Day 2025: Living well with diabetes and beyond

Novo Nordisk A/S: Candidate for the Board of Directors will not seek election

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

P3 Health Partners Announces Third Quarter 2025 Results

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026